Non-Langerhans cell histiocytoses

Writing Group of Histiocyte Society. Histiocytic syndromes in children. Lancet 1987; i: 208-9.

Snow JL, Su WPD. Histiocytic diseases. J Am Acad Dermatol 1995; 33: 111-23.

Burgdorf WHC. The histiocytoses. In: Elder D, Elenitsas R, Jaworsky C, Johnson B Jr, eds. Lever’s histopathology of the skin, 8th edn. Philadelphia: Lippincott-Raven; 1997. p. 591-616.

Eisen RN, Buckley PJ, Rosai J. Immunophenotypic characteristics of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Semin Diagn Pathol 1990; 7: 74-82.

Paulli M, Bergamaschi G, Tonon L et al. Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Br J Dermatol 2003; 91: 415-8.

Arico M, Allen M, Brusa S et al. Haemophagocytic lymphohistiocytosis. Proposal of a diagnostic algorithm based on perforin expression. Br J Hematol 2002; 119: 180-1.

Karras A, Hermine O. Hemophagocytic syndrome. Rev Med Interne 2002; 23: 768-78.

Zelger BWH. The histiocytoses. In: Dyall-Smith D, Marks R, eds. Dermatology at the millennium. Proceedings of the 19th World Congress of Dermatology. London: Parthenon Publishing Group. p. 343-7.

Ravelli A. Macrophage activation syndrome (MAS). Curr Opin Rheumatol 2002; 14: 548-52.

Lay JD, Chuang SE, Rowe M, Su IJ. Epstein-Barr virus latent membrane protein-1 mediates upregulation of tumour necrosis factor-alpha in EBV-infected T cells: implications for the pathogenesis of hemophagocytic syndrome. J Biomed Sci 2003; 10: 146-55.